Aliases & Classifications for Social Phobia

MalaCards integrated aliases for Social Phobia:

Name: Social Phobia 12 14
Phobic Anxiety Disorder 69
Phobic Disorders 41
Phobia, Social 69
Phobia Social 51

Classifications:



External Ids:

Disease Ontology 12 DOID:11257
ICD9CM 34 300.23
MeSH 41 D010698
NCIt 46 C34927
UMLS 69 C0031572

Summaries for Social Phobia

Disease Ontology : 12 A phobic disorder that involves social anxiety occurring only in specific public or social situations, interactions with others or being evaluated or scrutinized by other people.

MalaCards based summary : Social Phobia, also known as phobic anxiety disorder, is related to phobic disorder and agoraphobia. An important gene associated with Social Phobia is MAOA (Monoamine Oxidase A), and among its related pathways/superpathways are Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways and Serotonergic synapse. The drugs Norepinephrine and Citalopram have been mentioned in the context of this disorder. Affiliated tissues include brain, amygdala and testes, and related phenotypes are behavior/neurological and endocrine/exocrine gland

Related Diseases for Social Phobia

Diseases related to Social Phobia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 118)
# Related Disease Score Top Affiliating Genes
1 phobic disorder 33.8 MAOA SLC6A4
2 agoraphobia 30.9 MAOA SLC6A4
3 personality disorder 30.4 DRD2 MAOA SLC6A4
4 anxiety 30.4 CCK HTR3A MAOA SLC6A4
5 premature ejaculation 30.1 HTR3A SLC6A4
6 paraphilia disorder 30.0 MAOA PRL
7 panic disorder 30.0 CCK HTR3A MAOA SLC6A4
8 borderline personality disorder 30.0 MAOA SLC6A4
9 alcohol use disorder 29.6 DRD2 SLC6A4
10 generalized anxiety disorder 29.6 DRD2 HTR3A MAOA SLC6A4
11 bruxism 29.6 DRD2 SLC6A4
12 drug dependence 29.5 DRD2 SLC6A4
13 mood disorder 29.4 DRD2 MAOA SLC6A4
14 eating disorder 29.2 CCK DRD2 SLC6A4
15 obsessive-compulsive disorder 29.0 DRD2 HTR3A MAOA PRL SLC6A4
16 autism 28.8 DRD2 MAOA SLC6A4
17 major depressive disorder 28.2 DRD2 HTR3A MAOA PRL SLC6A4
18 bipolar disorder 28.2 DRD2 HTR3A MAOA PRL SLC6A4
19 schizophrenia 28.1 CCK DRD2 HTR3A MAOA PRL SLC6A4
20 alcohol dependence 28.0 CCK DRD2 HTR3A MAOA SLC6A4
21 avoidant personality disorder 10.5
22 atypical depressive disorder 10.3 MAOA SLC6A4
23 dysthymic disorder 10.3 MAOA SLC6A4
24 kleptomania 10.3 MAOA SLC6A4
25 mutism 10.2
26 head injury 10.2 PRL SOD1
27 intermittent explosive disorder 10.2 PRL SLC6A4
28 paranoid schizophrenia 10.2 MAOA SLC6A4
29 mental depression 10.2 MAOA SLC6A4
30 tetrahydrobiopterin deficiency 10.1 PRL SOD1
31 endogenous depression 10.1 MAOA SLC6A4
32 stereotypic movement disorder 10.1 CCK PRL
33 aging 10.1
34 ring chromosome y syndrome 10.1
35 postcholecystectomy syndrome 10.0 CCK SOD1
36 strabismus 10.0
37 phobia, specific 10.0
38 body dysmorphic disorder 10.0
39 separation anxiety disorder 10.0
40 chronic fatigue syndrome 10.0 MAOA SLC6A4
41 postpartum depression 10.0 MAOA PRL SLC6A4
42 functional gastric disease 10.0 CCK HTR3A
43 galactorrhea 10.0 DRD2 PRL
44 schizophreniform disorder 10.0 DRD2 PRL
45 prolactin producing pituitary tumor 10.0 DRD2 PRL
46 alcohol-induced mental disorder 10.0 DRD2 SLC6A4
47 functioning pituitary adenoma 9.9 DRD2 PRL
48 neurofibromatosis, type ii 9.9
49 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.9
50 stuttering 9.9

Comorbidity relations with Social Phobia via Phenotypic Disease Network (PDN):


Anxiety Dysthymic Disorder

Graphical network of the top 20 diseases related to Social Phobia:



Diseases related to Social Phobia

Symptoms & Phenotypes for Social Phobia

MGI Mouse Phenotypes related to Social Phobia:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.87 SOD1 CCK DRD2 HTR3A MAOA PRL
2 endocrine/exocrine gland MP:0005379 9.73 SOD1 CCK DRD2 HTR3A PRL SLC6A4
3 homeostasis/metabolism MP:0005376 9.7 SLC6A4 SOD1 CCK DRD2 HTR3A MAOA
4 integument MP:0010771 9.35 SLC6A4 SOD1 DRD2 HTR3A PRL
5 nervous system MP:0003631 9.17 SOD1 CCK DRD2 HTR3A MAOA PRL

Drugs & Therapeutics for Social Phobia

Drugs for Social Phobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 167)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Norepinephrine Approved Phase 4,Phase 3 51-41-2 439260
2
Citalopram Approved Phase 4,Phase 2,Phase 1 59729-33-8 2771
3
Ethanol Approved Phase 4,Phase 2 64-17-5 702
4
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
5
Sertraline Approved Phase 4,Phase 3,Phase 2,Phase 1 79617-96-2 68617
6
Cycloserine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 68-41-7 6234 401
7
Tiagabine Approved, Investigational Phase 4 115103-54-3 60648
8
Paroxetine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61869-08-7 43815
9
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
10
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
11 Piracetam Approved, Investigational Phase 4,Phase 2 7491-74-9
12
Dopamine Approved Phase 4,Phase 3,Phase 2 51-61-6, 62-31-7 681
13
Propranolol Approved, Investigational Phase 4,Phase 2 525-66-6 4946
14
Topiramate Approved Phase 4 97240-79-4 5284627
15
Ketamine Approved, Vet_approved Phase 4,Early Phase 1 6740-88-1 3821
16
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
17
Vortioxetine Approved, Investigational Phase 4 508233-74-7 9966051
18
Acetylcholine Approved Phase 4 51-84-3 187
19 Etiracetam Investigational Phase 4,Phase 2 33996-58-6
20 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
21 Psychotropic Drugs Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
22 Antidepressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
23 Antidepressive Agents, Second-Generation Phase 4,Phase 3,Phase 2,Phase 1
24 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
25 Neurotransmitter Uptake Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
26
Serotonin Phase 4,Phase 3,Phase 2,Phase 1 50-67-9 5202
27 Serotonin Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Serotonin Uptake Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
29 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
30 Antiparkinson Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
32 Cholinergic Agents Phase 4,Phase 2,Phase 1
33 Cholinergic Antagonists Phase 4,Phase 2,Phase 1
34 Muscarinic Antagonists Phase 4,Phase 2,Phase 1
35 Parasympatholytics Phase 4,Phase 2,Phase 1
36 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
37 Serotonin 5-HT1 Receptor Agonists Phase 4
38 Antipsychotic Agents Phase 4,Phase 2,Phase 3,Early Phase 1
39 Quetiapine Fumarate Phase 4,Phase 2,Phase 3,Early Phase 1 111974-72-2
40 Tranquilizing Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
41 Anticonvulsants Phase 4,Phase 2,Phase 3
42 GABA Agents Phase 4,Phase 1
43 GABA Modulators Phase 4,Phase 1
44 Serotonin and Noradrenaline Reuptake Inhibitors Phase 4,Phase 3
45 Venlafaxine Hydrochloride Phase 4,Phase 3
46 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
47 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
48 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
49 Antitubercular Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
50 Renal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 257)

# Name Status NCT ID Phase Drugs
1 The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment Completed NCT00407199 Phase 4 quetiapine
2 Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder Completed NCT00282828 Phase 4 Sertraline;Venlafaxine;Placebo;Clonazepam
3 D-Cycloserine Enhancement of Exposure in Social Phobia Completed NCT00633984 Phase 4 D-Cycloserine;Placebo
4 Nefazodone in the Treatment of Social Phobia Completed NCT00231348 Phase 4 Nefazodone
5 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder Completed NCT01316302 Phase 4 Pristiq;Placebo
6 Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder Completed NCT00208741 Phase 4 Gabitril
7 Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder Completed NCT00872131 Phase 4 Sertraline
8 Escitalopram in Patients With Social Anxiety Disorder Completed NCT00902226 Phase 4 Escitalopram
9 Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults Completed NCT01224067 Phase 4 Quetiapine
10 Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder Completed NCT00190879 Phase 4 Atomoxetine hydrochloride;placebo
11 Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism Completed NCT00246441 Phase 4 Paroxetine;Placebo
12 RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo Completed NCT00184106 Phase 4 Seroxat, Cognitive therapy, Seroxat+ cognitive therapy
13 Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents Completed NCT01160588 Phase 4 Sertraline
14 Primary Care Intervention Strategy for Anxiety Disorders Completed NCT00347269 Phase 4 Psychotropic medication optimization
15 Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety Completed NCT00177008 Phase 4 Aripiprazole
16 Acamprosate in Alcoholics With Comorbid Anxiety or Depression Completed NCT00330174 Phase 4 Acamprosate
17 Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Completed NCT00265109 Phase 4 Levetiracetam
18 Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity Completed NCT01863459 Phase 4 Lisdexamfetamine Dimesylate;placebo
19 Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP) Recruiting NCT00182455 Phase 4 Topiramate;Placebo
20 Ketamine Infusion for Adolescent Depression and Anxiety Recruiting NCT02579928 Phase 4 Ketamine;Midazolam
21 Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Active, not recruiting NCT00182533 Phase 4 Sertraline;Placebo
22 Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder Active, not recruiting NCT02294305 Phase 4 Vortioxetine;Placebo
23 Brief Intervention to Reduce Fear of Public Speaking Active, not recruiting NCT02790736 Phase 4 propranolol;placebo
24 A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder Terminated NCT03078270 Phase 4 botulinum toxin A
25 Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice Unknown status NCT01388231 Phase 2, Phase 3
26 Treatment of Social Phobia and Panic Disorder in Adults Completed NCT00619138 Phase 3
27 Residential Cognitive and Interpersonal Therapy for Social Phobia Completed NCT00326430 Phase 2, Phase 3
28 A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy Completed NCT00564967 Phase 3
29 Treatment of Childhood Social Phobia Completed NCT00043537 Phase 3 Fluoxetine;Pill Placebo
30 Quetiapine in Social Anxiety Disorder Completed NCT00215254 Phase 2, Phase 3 quetiapine
31 Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia Completed NCT00515879 Phase 3 D-cycloserine;Placebo
32 Social Anxiety Disorder Study Of Paroxetine Completed NCT00318669 Phase 3 Paroxetine hydrochloride hydrate
33 Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD) Completed NCT02622958 Phase 3 PH94B
34 Flushing in Social Anxiety Disorder on Seroquel Completed NCT00773162 Phase 3 Seroquel;Sugar Pill
35 Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder Completed NCT00260533 Phase 2, Phase 3 atomoxetine;placebo
36 Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder Completed NCT00074802 Phase 3 Paroxetine
37 Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder Completed NCT00238719 Phase 3 Venlafaxine ER
38 Long-term Study Of Paroxetine in Women and Men Completed NCT00264654 Phase 3 BRL29060A;paroxetine hydrochloride hydrate
39 Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety Completed NCT00958880 Phase 3 Yohimbine Hydrochloride;Sugar Pill
40 St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) Completed NCT00118833 Phase 2, Phase 3 Hypericum perforatum (St. John's wort)
41 Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome Completed NCT00114127 Phase 3 Duloxetine;Duloxetine;Placebo
42 A Systems Level Intervention for Unemployed Persons With Social Anxiety Disorder Completed NCT01654510 Phase 2, Phase 3
43 A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder Completed NCT00411398 Phase 3 Namenda/Memantine
44 Treatment for Anxiety in Children Completed NCT00000389 Phase 3 Fluvoxamine
45 Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers Completed NCT01416805 Phase 3
46 Child and Adolescent Anxiety Disorders (CAMS) Completed NCT00052078 Phase 3 Sertraline (SRT);Placebo
47 Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders Completed NCT01178385 Phase 2, Phase 3
48 Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder Recruiting NCT03017508 Phase 2, Phase 3 BHV-0223;Placebo
49 Psychotherapy for Anxiety in Children With Autism Spectrum Disorder Active, not recruiting NCT02028247 Phase 3
50 Efficacy of Quetiapine in Generalised Social Anxiety Disorder Terminated NCT00302770 Phase 3 quetiapine

Search NIH Clinical Center for Social Phobia

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: phobic disorders

Genetic Tests for Social Phobia

Anatomical Context for Social Phobia

MalaCards organs/tissues related to Social Phobia:

38
Brain, Amygdala, Testes, Heart, Cortex, Pituitary, Hypothalamus

Publications for Social Phobia

Articles related to Social Phobia:

(show top 50) (show all 613)
# Title Authors Year
1
Psychometric Evaluation of the Social Phobia Inventory and the Mini-Social Phobia Inventory in a Swedish University Student Sample. ( 29375026 )
2018
2
Avoidant personality disorder and social phobia: Does mindreading make the difference? ( 29096207 )
2018
3
Daily fluctuation of emotions and memories thereof: Design and methods of an experience sampling study of major depression, social phobia, and controls. ( 28948700 )
2017
4
Confirmatory Factor Analysis of the Combined Social Phobia Scale and Social Interaction Anxiety Scale: Support for a Bifactor Model. ( 28210232 )
2017
5
Mini - social phobia inventory (mini-SPIN): psychometric properties and population based norms of the German version. ( 29178857 )
2017
6
Depression and social phobia in essential tremor and Parkinson's disease. ( 28948077 )
2017
7
Social phobia, depression and eating disorders during middle adolescence: longitudinal associations and treatment seeking. ( 28868945 )
2017
8
Collaborative care for panic disorder, generalised anxiety disorder and social phobia in general practice: study protocol for three cluster-randomised, superiority trials. ( 28814317 )
2017
9
Identifying sub-categories of social fears using an alternative factor analytic structure of the Social Phobia and Anxiety Inventory. ( 28236783 )
2017
10
Comorbidity of schizophrenia and social phobia - impact on quality of life, hope, and personality traits: a cross sectional study. ( 28831256 )
2017
11
Community-Based Validation of the Social Phobia Screener (SOPHS). ( 26939801 )
2016
12
The effect of Interaction Anxiousness Scale and Brief Social Phobia Scale for screening social anxiety disorder in college students: a study on discriminative validity. ( 27935389 )
2016
13
Psychometric properties of the mini-social phobia inventory (Mini-SPIN) in a large online treatment-seeking sample. ( 27046641 )
2016
14
Attentional mechanisms of social perception are biased in social phobia. ( 27131909 )
2016
15
Factor solutions of the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS) in a Swedish population. ( 27894213 )
2016
16
Retracted: Combined Case of Blood-Injury-Injection Phobia and Social Phobia: Behavior Therapy Management and Effectiveness through Tilt Test. ( 27722005 )
2016
17
No effects of psychosocial stress on memory retrieval in non-treated young students with Generalized Social Phobia. ( 27464065 )
2016
18
Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections. ( 28082921 )
2016
19
Hypochondriasis Differs From Panic Disorder and Social Phobia: Specific Processes Identified Within Patient Groups. ( 27805984 )
2016
20
Virtual reality exposure using three-dimensional images for the treatment of social phobia. ( 26561376 )
2016
21
Autonomic markers associated with generalized social phobia symptoms: heart rate variability and salivary alpha-amylase. ( 27892761 )
2016
22
Examination of the Correlation Between Internet Addiction and Social Phobia in Adolescents. ( 27561297 )
2016
23
Social Phobia: The Role of In-Situation Safety Behaviors in Maintaining Anxiety and Negative Beliefs - Republished Article. ( 27816079 )
2016
24
Assimilation, reflexivity, and therapist responsiveness in group psychotherapy for social phobia: A case study. ( 27092848 )
2016
25
Selective Mutism: The Fraternal Twin of Childhood Social Phobia. ( 27089281 )
2016
26
Intensive Group-Based CBT for Child Social Phobia: A Pilot Study. ( 25892171 )
2015
27
Comparison of automatical thoughts among generalized anxiety disorder, major depressive disorder and generalized social phobia patients. ( 26241548 )
2015
28
An experimental investigation of the functional relationship between social phobia and cigarette smoking. ( 25576952 )
2015
29
Behavioral treatment of social phobia in youth: Does parent education training improve the outcome? ( 25727679 )
2015
30
Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia. ( 26288643 )
2015
31
Correction: Avoidant Personality Disorder versus Social Phobia: The Significance of Childhood Neglect. ( 25978045 )
2015
32
Reprint of: Social phobia and other psychiatric problems in children with strabismus. ( 26049893 )
2015
33
Attachment styles in patients with avoidant personality disorder compared with social phobia. ( 26332087 )
2015
34
Developmental Differences in Functioning in Youth With Social Phobia. ( 26630122 )
2015
35
Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN). ( 26454660 )
2015
36
Social anxiety disorders in clinical practice: differentiating social phobia from avoidant personality disorder. ( 26129819 )
2015
37
Correction: The Neuroanatomical Basis of Panic Disorder and Social Phobia in Schizophrenia: A Voxel Based Morphometric Study. ( 25906143 )
2015
38
The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. ( 25774979 )
2015
39
Social phobia and quality of life in morbidly obese patients before and after bariatric surgery. ( 25863007 )
2015
40
Social Phobia and Educational and Interpersonal Impairments in Adolescence: A Prospective Study. ( 26514560 )
2015
41
Avoidant Personality Disorder versus Social Phobia: The Significance of Childhood Neglect. ( 25815817 )
2015
42
The contribution of the therapist's competence in the treatment of adolescents with generalized social phobia. ( 25340895 )
2014
43
The dutch social interaction anxiety scale and the social phobia scale: reliability, validity, and clinical utility. ( 24701560 )
2014
44
Children with social phobia have lower quality friendships than children with other anxiety disorders. ( 25337769 )
2014
45
Hypnosis aided fixed role therapy for social phobia: a case report. ( 24938079 )
2014
46
Prevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorder. ( 25289805 )
2014
47
Subliminal cues bias perception of facial affect in patients with social phobia: evidence for enhanced unconscious threat processing. ( 25136307 )
2014
48
Clinical experiences in conducting cognitive-behavioral therapy for social phobia. ( 24411111 )
2014
49
Social phobia among long-term internally displaced persons: An epidemiological study of adults in two internally displaced person settlements in Sudan. ( 25540300 )
2014
50
Comparing Short Forms of the Social Interaction Anxiety Scale and the Social Phobia Scale. ( 24932648 )
2014

Variations for Social Phobia

Expression for Social Phobia

Search GEO for disease gene expression data for Social Phobia.

Pathways for Social Phobia

GO Terms for Social Phobia

Cellular components related to Social Phobia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuronal cell body GO:0043025 9.13 CCK HTR3A SOD1
2 axon GO:0030424 8.8 CCK DRD2 HTR3A

Biological processes related to Social Phobia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.54 DRD2 SLC6A4 SOD1
2 excitatory postsynaptic potential GO:0060079 9.4 DRD2 HTR3A
3 response to cocaine GO:0042220 9.32 DRD2 HTR3A
4 response to axon injury GO:0048678 9.26 DRD2 SOD1
5 regulation of multicellular organism growth GO:0040014 9.16 PRL SOD1
6 response to amphetamine GO:0001975 8.96 DRD2 SOD1
7 response to ethanol GO:0045471 8.8 DRD2 HTR3A SOD1

Sources for Social Phobia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....